Position in NVS
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$709,628
+$17,976 QoQ
Shares Held
4,528
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
#745
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Hanson & Doremus Investment Management holds $28,323,234 across 13 Drug Manufacturers - General names. NVS ranks #9 (2.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
56,094 | $7,208,079 | |
| 2 | LLY |
ELI LILLY & Co
|
3,655 | $4,383,917 | |
| 3 | ABBV |
AbbVie Inc.
|
16,581 | $4,172,442 | |
| 4 | JNJ |
Johnson & Johnson
|
16,303 | $4,140,472 | |
| 5 | AMGN |
Amgen Inc
|
10,917 | $3,953,264 | |
| 6 | AZN |
Astrazeneca PLC
|
5,916 | $1,121,791 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
18,157 | $1,046,206 | |
| 8 | PFE |
Pfizer Inc
|
35,388 | $852,143 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $709,628 | 4,528 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $691,652 | 4,528 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $86,168 | 625 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $86,433 | 674 | Shares | Sole | 2025-10-15 | |
| 2025-06-30 | $75,631 | 625 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $504,781 | 4,528 | Shares | Sole | 2025-04-17 | |
| 2024-12-31 | $60,818 | 625 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $71,887 | 625 | Shares | Sole | 2024-10-17 | |
| 2024-06-30 | $78,780 | 740 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $71,580 | 740 | Shares | Sole | 2024-04-22 | |
| 2023-12-31 | $74,717 | 740 | Shares | Sole | 2024-01-25 | |
| 2023-09-30 | $75,376 | 740 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $74,673 | 740 | Shares | Sole | 2023-07-18 | |
| 2023-03-31 | $68,080 | 740 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $421,212 | 4,643 | Shares | Sole | 2023-01-18 | |
| 2022-09-30 | $60,884 | 801 | Shares | Sole | 2022-10-20 | |
| 2022-06-30 | $79,289 | 938 | Shares | Sole | 2022-07-19 | |
| 2022-03-31 | $85,293 | 972 | Shares | Sole | 2022-04-22 | |
| 2021-12-31 | $74,961 | 857 | Shares | Sole | 2022-01-20 | |
| 2021-09-30 | $70,085 | 857 | Shares | Sole | 2021-10-21 | |
| 2021-06-30 | $98,174 | 1,076 | Shares | Sole | 2021-07-22 | |
| 2021-03-31 | $410,560 | 4,803 | Shares | Sole | 2021-05-03 | |
| 2020-12-31 | $449,486 | 4,760 | Shares | Sole | 2021-02-01 | |
| 2020-09-30 | $93,568 | 1,076 | Shares | Sole | 2020-10-19 | |
| 2020-06-30 | $93,977 | 1,076 | Shares | Sole | 2020-07-17 | |
| 2020-03-31 | $391,390 | 4,747 | Shares | Sole | 2020-04-24 | |
| No filing history on record for this holder in this stock. | ||||||